Jianping Jia

Active 2005–2025

135
Papers
17,929
Citations
55
h-index
119
i10-index

Citations

Citations per year for Jianping Jia2000: 1 citations2004: 1 citations2005: 2 citations2007: 4 citations2008: 5 citations2009: 7 citations2010: 7 citations2011: 17 citations2012: 41 citations2013: 62 citations2014: 86 citations2015: 97 citations2016: 90 citations2017: 100 citations2018: 135 citations2019: 447 citations2020: 615 citations2021: 803 citations2022: 951 citations2023: 796 citations2024: 1,457 citations2025: 699 citations2026: 30 citations2001–2003: no citations, so these years are not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,194 citing papers, 35.1% of this breakdownUnited States: 1,551 citing papers, 17% of this breakdownUnited Kingdom: 509 citing papers, 5.6% of this breakdownCanada: 256 citing papers, 2.8% of this breakdownAustralia: 252 citing papers, 2.8% of this breakdownItaly: 240 citing papers, 2.6% of this breakdownGermany: 234 citing papers, 2.6% of this breakdownIndia: 183 citing papers, 2% of this breakdownSweden: 181 citing papers, 2% of this breakdownSpain: 174 citing papers, 1.9% of this breakdownFrance: 169 citing papers, 1.8% of this breakdownSouth Korea: 161 citing papers, 1.8% of this breakdown
0%35.1%Other 22%

Fields

  • Medicine58.3%
  • Neuroscience17.3%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Psychology1.9%
  • Health Professions1.4%
  • Computer Science1%
  • Other5.9%

Topics

  • Alzheimer's disease research and treatments7.7%
  • Dementia and Cognitive Impairment Research7.6%
  • Acute Ischemic Stroke Management3.3%
  • Functional Brain Connectivity Studies3.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Neurological Disease Mechanisms and Treatments2.6%
  • Other72.3%

Coauthors

All papers

Open in search
  1. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yan Lv, Li Yang, Minchen Kan, Huiying Zhao, S.H. Wang, Shanshan Yang, Hao Li, Zhongling Liu, Qi Wang, Wei Qin, Jianping Jia, Meina Quan, Yan Wang, Wenwen Li, Shuman Cao, Lingzhi Xu, Yue Han, Junhua Liang, Yuchen Qiao, Qi Qin, Qiongqiong Qiu - The Lancet Public Health 2020 cited by 1,704

  2. Stroke in China: advances and challenges in epidemiology, prevention, and management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chuanqiang Pu, Jianping Jia, Tong Zhang, Xinfeng Liu, Suming Zhang, Peng Xie, Dongsheng Fan, Xunming Ji, Ka Sing Wong, Longde Wang, Chenchen Wei, Yanan Wang, Yajun Cheng, Yunhai Liu, Xin Li, Qiang Dong, Jinsheng Zeng, Bin Peng, Yun Xu, Yi Yang, Yilong Wang, Gang Zhao, Wei Wang, Yuming Xu, Qingwu Yang, Zhiyi He, Shaoshi Wang, Chao You, Ying Gao, Dong Zhou, Li He, Zixiao Li, Jie Yang, Chunyan Lei, Yuhua Zhao, Junfeng Liu, Shuting Zhang, Wendan Tao, Zilong Hao, Deren Wang, Shihong Zhang - The Lancet Neurology 2019 cited by 1,613

  3. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 396

  4. Dementia in China: epidemiology, clinical management, and research advances

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2019 cited by 861

  5. The cost of Alzheimer's disease in China and re‐estimation of costs worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enyan Yu, Benyan Luo, Yan‐Jiang Wang, Shanshan Yang, Qiumin Qu, Qihao Guo, Furu Liang, Jintao Zhang, Lan Tan, Lu Shen, Kunnan Zhang, Jinbiao Zhang, Dantao Peng, Muni Tang, Peiyuan Lv, Boyan Fang, Lan Chu, Longfei Jia, Serge Gauthier - Alzheimer s & Dementia 2018 cited by 754

  6. Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2019 cited by 377

  7. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,838

  8. Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage

    Authors: , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 256

  9. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2023 cited by 241

  10. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 487

  11. Chinese Mini Mental Status in Elderly Chinese: A Population-Based Normative Study

    Authors: , , - Journal of Alzheimer s Disease 2016 cited by 564

  12. Montreal Cognitive Assessment in Detecting Cognitive Impairment in Chinese Elderly Individuals: A Population-Based Study

    Authors: , , , , , , , , - Journal of Geriatric Psychiatry and Neurology 2011 cited by 562

  13. Gut inflammation triggers C/EBPβ/δ‐secretase‐dependent gut‐to‐brain propagation of Aβ and Tau fibrils in Alzheimer’s disease

    Authors: , , , , , , , , - The EMBO Journal 2021 cited by 133

  14. Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer’s Disease

    Authors: , - Frontiers in Immunology 2021 cited by 153

  15. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease

    Authors: , , , , - Journal of Alzheimer s Disease 2021 cited by 128

  16. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

    Authors: , , , , , , , , , , , , - Nature Communications 2015 cited by 279

  17. Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Alzheimer s Disease 2017 cited by 217

  18. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis

    Authors: , , , , - Nutrition Reviews 2021 cited by 140

  19. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population

    Authors: , , , , , - The Lancet Regional Health - Western Pacific 2023 cited by 106

  20. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway

    Authors: , - Biomedicine & Pharmacotherapy 2023 cited by 100

  21. The prevalence of dementia in urban and rural areas of China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2013 cited by 454

  22. Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy

    Authors: , , , , - Phenomics 2023 cited by 52

  23. Disrupted Functional Brain Connectome in Individuals at Risk for Alzheimer's Disease

    Authors: , , , , , , , , - Biological Psychiatry 2012 cited by 433

  24. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 136